Equities
  • Price (USD)31.26
  • Today's Change-0.705 / -2.21%
  • Shares traded61.89k
  • 1 Year change+782.61%
  • Beta0.6689
Data delayed at least 15 minutes, as of Mar 03 2026 19:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 26-Feb-26
Select bar for recommendation details.
Recommendations26-Feb-26
Buy4
Outperform3
Hold1
Sell0
Strong Sell0

Share price forecast in EUR

The 3 analysts offering 12 month price targets for Nanobiotix SA - ADR have a median target of 25.74, with a high estimate of 25.74 and a low estimate of 25.43. The median estimate represents a -19.47% decrease from the last price of 31.96.
High-19.5%25.74
Med-19.5%25.74
Low-20.4%25.43

Earnings history & estimates in EUR

On Sep 26, 2023, losses of -0.80 per share.
Nanobiotix SA - ADR reported annual 2024 losses of -1.44 per share on Apr 02, 2025.
Average growth rate-3.72%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.